Cynata Therapeutics Limited (CYP.AX)
Develops stem cell therapies to treat immune, joint, wound, and transplant diseases.
0.01+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-92.9%
The outlook
CYP.AX is trading near its 52-week low at $0.012, significantly below both its 50- and 200-day moving averages, reflecting a weak downtrend. Analyst coverage appears thin or unavailable. The current data shows a bearish lean with minimal recent price movement.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$2.9M
52-wk high
0.44
52-wk low
0.01
50-day avg
0.12
200-day avg
0.26
Trailing P/E
—